EPO Patents = 1

Forward Citations = 5

Loading Chart...

3 inventors (with patents filed for the assignee):

David Martin Kaye (4 out of 22 patents)

Guy Krippner (3 out of 4 patents)

Geetha Thanga Mariappan (3 out of 4 patents)

4 patents: Sort by Forward Citations

1. 10736853 - Milrinone controlled-release formulation (2020-08-11),

2. 10517833 - Uses of milrinone controlled-release formulation (2019-12-31),

3. 10493067 - Method of treating heart failure with preserved ejection fraction by administering milrinone (2019-12-03),

4. 10137093 - Milrinone controlled-release formulation (2018-11-27),

Cardiora Pty Ltd. is a leading biomedical company specializing in the research, development, and production of advanced cardiac monitoring systems. Our innovative technologies are designed to provide accurate and reliable data to healthcare professionals, enabling them to make informed decisions for their patients' well-being. With a strong commitment to excellence and continual improvement, Cardiora is dedicated to enhancing the quality of patient care globally.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 16 2025

4 Patents

#39 in Melbourne

#983 in Australia

Melbourne, Australia

Cardiora Pty Ltd.

Forward Citations = 5

3 inventors:

David Martin Kaye (4 out of 22 patents)

Guy Krippner (3 out of 4 patents)

Geetha Thanga Mariappan (3 out of 4 patents)

Please report any incorrect information to support@idiyas.com

1 patent (EPO):

Please report any incorrect information to support@idiyas.com